Benefits of Arthrosamid for Knee Osteoarthritis: OA Pain Relief Guide Updated

MSK Doctors, a specialist clinic offering advanced, minimally invasive, and regenerative treatments, has updated its comprehensive report on Arthrosamid, the first single-injection treatment to offer long-term pain and stiffness relief for osteoarthritis.

-- A new report from MSK Doctors explores the benefits of Arthrosamid, a single-injection knee treatment, in comparison to traditional options for osteoarthritis knee pain. The report highlights how this new option can reduce pain and stiffness for several years, or maybe longer, from a single treatment.

More information about Arthrosamid for osteoarthritis knee pain and stiffness, the results of recent clinical trials, and options for speaking to specialist can be found at https://mskdoctors.com/treatments/arthrosamid

For more than two decades, Arthrosamid has been making its way through clinical trials, with promising results that suggest it can be equally or more effective than traditional injection treatments. While Arthrosamid is similar to traditional treatments in many ways, it differs by using a non-biodegradable polymer, which helps it to stay in the body for up to several years, instead of only months.

While there are several known treatments that can help to reduce or eliminate knee pain and stiffness for up to 6 months, Arthrosamid is the first treatment to be clinically proven to offer the same benefits for up to 2 years, or longer. The full report explains that this is due to the non-biodegradable nature of the treatment, which gives it the potential to act as a long-term scaffold for tissue regeneration.

Although this new compound has been tested extensively for more than 20 years, no long-lasting adverse side effects have been reported in any of the clinical trials to date. The most commonly reported side effects include temporary swelling, itching, or redness at the injection site, which usually fades within a few days.

Individuals who are suffering from osteoarthritis knee pain are encouraged to speak to a local specialist about Arthrosamid, and to ask whether this treatment may be effective for them. However, as a newly approved treatment, it can be difficult to find experienced clinicians.

Prof. Paul Lee, the founder of MSK Doctors in London, is one of the first UK clinicians approved to provide Arthrosamid, and as a result, is still one of the most experienced local specialists. New patients can book their own appointments online for consultation, diagnosis, or treatment, with no waiting list and no GP referral required.

An excerpt from the full report explains, “Arthrosamid… presents a promising and innovative treatment option for knee osteoarthritis. Its unique mechanism of action, involving the provision of a scaffold for the synovial membrane, offers a new avenue for tissue regeneration. Clinical studies and real-world patient stories corroborate its efficacy, safety, and long-term benefits.”

More information about Arthrosamid specialists, pain relief duration, and options for self-booking an appointment can be found at https://mskdoctors.com/treatments/arthrosamid

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89155061

Should you detect any errors, issues, or discrepancies with the content contained within this press release, or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond and take necessary steps within the next 8 hours to resolve any identified issues or guide you through the removal process. We value the trust placed in us by our readers and remain dedicated to providing accurate and reliable information.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.